The value of case reports in pharmacovigilance
Br J Dermatol
.
2020 Nov;183(5):795-796.
doi: 10.1111/bjd.19504.
Authors
I Garcia-Doval
1
2
,
E Segovia
3
,
H Hunter
4
,
J Frew
5
,
L Naldi
6
7
Affiliations
1
Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
2
Research Unit, Fundación Piel Sana Academia Española de Dermatología, Madrid, Spain.
3
Risk Assessment Unit, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
4
Department of Dermatology, Salford Royal NHS Foundation Trust, Manchester, UK.
5
Department of Dermatology, Prince of Wales Hospital, Sydney, NSW, Australia.
6
Study Center of the Italian Group for Epidemiologic Research in Dermatology (GISED), Via Clara Maffei 4, 24121, Bergamo, Italy.
7
Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
PMID:
33135791
DOI:
10.1111/bjd.19504
No abstract available
Publication types
Case Reports
Editorial
MeSH terms
Adverse Drug Reaction Reporting Systems
Databases, Factual
Drug-Related Side Effects and Adverse Reactions*
Humans
Pharmacovigilance*